-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on ProMIS Neurosciences, Raises Price Target to $100

Benzinga·08/14/2026 13:29:22
Listen to the news
Guggenheim analyst Yatin Suneja maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $69 to $100.